NCT00040196View on ClinicalTrials.gov

How the Loss of Dopamine and Dopamine-Restoring Medicines Affect Movement Performance

CompletedOBSERVATIONAL
Enrollment

133

Participants

Timeline

Start Date

June 19, 2002

Primary Completion Date

July 9, 2009

Study Completion Date

July 9, 2009

Conditions
Parkinson Disease
Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
lead

National Institute of Neurological Disorders and Stroke (NINDS)

NIH

NCT00040196 - How the Loss of Dopamine and Dopamine-Restoring Medicines Affect Movement Performance | Biotech Hunter | Biotech Hunter